BioVaxys Technology Corp.
BVAXF
$0.0295
-$0.0026-8.10%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.67% | 49.32% | 74.27% | 56.22% | 46.82% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.58% | -55.09% | -85.00% | -72.12% | -57.38% |
| Change in Net Operating Assets | -100.61% | -97.30% | -30.08% | 40.91% | 1.45% |
| Cash from Operations | -267.37% | -74.94% | 33.46% | 65.25% | 51.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 86.50% | 244.63% | 89.91% | 32.50% | 18.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.75% | 239.20% | 90.60% | 31.91% | 15.50% |
| Foreign Exchange rate Adjustments | -26.67% | 170.83% | 106.51% | 84.25% | -126.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.83% | 251.20% | 1,414.49% | 255.04% | 1,190.12% |